EBITDA: Income before interest, taxes, depreciation and amortization.
Satellos Bioscience Inc. (T.MSL) had EBITDA of -1.12M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
0.95M |
|
-- |
|
-- |
|
-- |
|
-1.13M |
|
-- |
|
0.95M |
|
0.95M |
|
0.95M |
|
0.95M |
|
0.95M |
|
0.95M |
|
-1.13M |
|
|
EBITDA |
-1.12M |
0.35M |
|
0.35M |
|
-1.85 |
|
-1.85 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
1.06M |
|
-- |
|
-- |
|
-- |
|
0.22M |
|
0.84M |
|
0.84M |
|
0.84M |
|
0.35M |
|
| Cash Flow Statement Financials | |
-0.94M |
|
-- |
|
-- |
|
1.82M |
|
0.87M |
|
-0.95M |
|
0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
113.80% |
|
113.80% |
|
89.95% |
|
113.80% |
|
3.09 |
|
-2.67 |
|
-2.67 |
|